Elias U.S.A., Inc.

Elias U.S.A., Inc. — FDA 510(k) Submissions

Elias U.S.A., Inc. has submitted 54 FDA 510(k) premarket notifications since 1992, of which 54 received clearance as substantially equivalent to a predicate device.

The company's most frequent device categories include Antinuclear Antibody (enzyme-labeled), Antigen, Controls, System, Test, Anticardiolipin Immunological, System, Test, Thyroid Autoantibody, Extractable Antinuclear Antibody, Antigen And Control, Antinuclear Antibody, Antigen, Control . Use the specialty filter in the sidebar to narrow results.